Inventor of UCSD Licensed Technology Joins SAB

Batu Biologics Recruits Inventor of Licensed UCSD Cancer Immunotherapy to Scientific Advisory Board
Dr. Messmer to Assist in the Clinical Development of the ValloVax™ Lung Cancer Vaccine

Batu Biologics, an immunotherapy company developing the ValloVax™ anti-angiogenic lung cancer vaccine, announced today the addition Dr. Davorka Messmer to its Scientific Advisory Board (SAB).

Read the full article at